Elena Shagisultanova (@doctor_nova) profile picture

MD, specializing in young women's breast cancer

University of Colorado, Denver
Joined December 2015
Photo by Elena Shagisultanova (@doctor_nova)Photo by Elena Shagisultanova (@doctor_nova)
Elena Shagisultanova retweeted
No difference in recurrence among DCIS pts taking anastrozole or tamoxifen the.aacr.org/Qw2 #SABCS15
4
2
#aacr #sabcs #SABCSchat KEYNOTE study: pembrolizumab in ER+/HER2- cancer RR 12%, clinical benefit 20% - combination immunotherapy needed
2
#aacr #sabcs15 #sabcschat Dear patients, do not smoke! Risk of lung cancer in a smoker after breast RT goes up (9.4 to 13.8%) - EBCTCG study
1
4
#aacr #scbcschat #sabcs15 Very interesting cell lines and mice data that PDK1 inhibition synergizes with CDK4/6 inhibition Poster # PD2-06
1
2
TMA analysis of blocks from DBCG77B trial - luminal A patients may not benefit from chemo? To be reconciled with upcoming RxSPONDER results
1
#aacr #sabcschat #sabcs15 More MANTICORE slides - patients on beta-blockers had less interruptions of herceptin
1
#sabcschat #sabcs15 #aacr Results of MANTICORE randomized trial (beta blockers prevent LV dysfunction on Herceptin)
1
#sabcschat #sabcs15 #aacr SWOG-8814 retrospective analysis is not enough to use Oncotype in ER+ LN+ pnt, will await RxSPONDER results 2016
1
4
#sabcschat #sabcs15 #aacr Dr. Hayes (Univ. of Michigan): no evidence to withhold chemo in HR+ lymph node + patient with low Oncotype score
1
4
#aacr #sabcschat Great efforts from ENIGMA consortium: enigmaconsortium.org/ - classifying breast cancer risk associated with various VUS.
1
#sabcschat #aacr Now I will refer all my patients with VUS to PROMT registry promptinfo.squarespace.com/a… - helping to reclassify VUS!
1
#sabcschat #aacr Excellent session on hereditary predisposition to breast cancer by Domchek, Robson and Couch!
1
2
#sabcschat #aacr Going to San Antonio Breast Cancer symposium tomorrow - very excited about it!
2